Progestogen-Androgen Combination: Results of Indonesian Clinical Trials
نویسنده
چکیده
This article summarizes the results of two recent WHO supported clinical studies in Indonesia to assess the potential of progestogen-androgen combinations as a development, TheJirst study was carried ou and at two dose levels: 100 mg DMPA ptus is carried out in Indonesia, in which male v I9-NT. In both cases, 250 mg DMPA was injected IM at week 0, 6, the first seven weekls and then at 3-weekly intervals until week 24. g a safe and effective hormonal contracep gh levels of hormones that needed to be i c urre n t ly av ai lab le c o mp o unds.
منابع مشابه
A double blind randomized control trial, comparing effect of drospirenone and gestodene to sexual desire and libido.
BACKGROUND Oral contraceptive is the most commonly used method of fertility control. Yasmin is a combination of a novel progestogen with anti-androgenic and anti-mineralcorticoid activities (3 mg Drospirenone (DRSP) and 30 microg ethinylestradiol (EE)). It has been shown in many clinical trials that Yasmin is an efficacious oral contraceptive, lacking undesired effects as with other oral contra...
متن کاملP-91: Androgen Associated Gene Polymorphism(s) in Women with Polycystic Ovary Syndrome from South Indian Population
Background: Polycystic ovary syndrome (PCOS) is a heterogeneous endocrine disorder affecting 4-12% of reproductive women worldwide; characterized by chronic anovulation, clinical and/or biochemical hyperandrogenism, and polycystic ovaries on ultrasound scan. Ovarian androgen overproduction is the key pathophysiologic feature of PCOS. A number of genes encoding major enzymes of the androgen meta...
متن کاملOral contraception: properties and side-effects of COCs and POPs
Combined oral contraceptives In the UK combined oral contraceptives (COCs), containing both oestrogen and progestogen, are the most popular method of contraception for women under age 30. The most common oestrogen used is ethinyl estradiol (EE), in doses between 20 and 35μg. Progestogens are classified according to their steroid structure and the timing of their introduction on to the market. T...
متن کاملCurrent status of hormone therapy and breast cancer.
This editorial comments on two similar reviews of the literature on breast cancer and post-menopausal hormone therapies (HTs), puts the results in clinical perspective and suggests where they direct future research and clinical management. Although epidemiological studies have suggested increased breast cancer risk for all menopausal HT regimens, unopposed oral estrogen regimens have not been a...
متن کاملA patient-level data meta-analysis of standard-of-care treatments from eight prostate cancer clinical trials
Open clinical trial data offer many opportunities for the scientific community to independently verify published results, evaluate new hypotheses and conduct meta-analyses. These data provide valuable opportunities for scientific advances in medical research. Herein we present the comparative meta-analysis of different standard of care treatments from newly available comparator arm data from se...
متن کامل